pyrazines has been researched along with Albuminuria in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Gordeuk, VR; Han, J; Hussain, F; Molokie, RE; Njoku, F; Saraf, SL | 1 |
Fujita, H; Hayashi, H; Kikuchi, N; Komatsu, K; Komatsu, T; Murayama, H; Narita, T; Ohshiro, H; Sato, S; Taniai, H; Yamada, Y | 1 |
Fukumoto, M; Hiura, Y; Hosoi, M; Ikuno, Y; Kawasaki, I; Okada, M; Tamai, A; Tanaka, N; Ueno, H; Yakusiji, Y; Yamagami, K; Yoshida, Y | 1 |
Hattori, S | 1 |
Aono, M; Fukushima, T; Harashima, SI; Inagaki, N; Koizumi, T; Murata, Y; Ogura, M; Seike, M; Tanaka, D; Wang, Y | 1 |
Chen, S; Li, JW; Ma, SX; Wang, Y; Yan, YH | 1 |
Hamada, N; Nagase, M | 1 |
3 trial(s) available for pyrazines and Albuminuria
Article | Year |
---|---|
DPP-4 inhibition with alogliptin on top of angiotensin II type 1 receptor blockade ameliorates albuminuria via up-regulation of SDF-1α in type 2 diabetic patients with incipient nephropathy.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Chemokine CXCL12; Cross-Over Studies; Cyclic AMP; Deoxyguanosine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dipeptidyl-Peptidase IV Inhibitors; Female; Humans; Male; Middle Aged; Piperidines; Pyrazines; Receptor, Angiotensin, Type 1; Sitagliptin Phosphate; Triazoles; Up-Regulation; Uracil | 2014 |
Sitagliptin reduces albuminuria in patients with type 2 diabetes.
Topics: Albuminuria; Anti-Inflammatory Agents; Blood Pressure; C-Reactive Protein; Creatinine; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Female; Glomerular Filtration Rate; Humans; Hypoglycemic Agents; Male; Middle Aged; Pyrazines; Sitagliptin Phosphate; Triazoles | 2011 |
Sitagliptin add-on to low dosage sulphonylureas: efficacy and safety of combination therapy on glycaemic control and insulin secretion capacity in type 2 diabetes.
Topics: Aged; Albuminuria; Blood Glucose; Blood Pressure; Body Mass Index; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Insulin Secretion; Male; Middle Aged; Prospective Studies; Pyrazines; Sitagliptin Phosphate; Sulfonylurea Compounds; Treatment Outcome; Triazoles | 2012 |
4 other study(ies) available for pyrazines and Albuminuria
Article | Year |
---|---|
Voxelotor and albuminuria in adults with sickle cell anaemia.
Topics: Adult; Albuminuria; Anemia, Sickle Cell; Benzaldehydes; Humans; Pyrazines; Pyrazoles | 2022 |
Sitagliptin reduces the urine albumin-to-creatinine ratio in type 2 diabetes through decreasing both blood pressure and estimated glomerular filtration rate.
Topics: Albuminuria; Blood Pressure; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Kidney Function Tests; Male; Middle Aged; Pyrazines; Sitagliptin Phosphate; Triazoles | 2015 |
Effect of new thromboxane A2 synthesis inhibitor tetramethyl-pyrazine on pancreatic transplantation in diabetic rats.
Topics: Albuminuria; Animals; Benzofurans; beta 2-Microglobulin; Cyclosporine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme Inhibitors; Immunosuppressive Agents; Kidney; Organ Size; Pancreas Transplantation; Pyrazines; Rats; Rats, Wistar; Thromboxane A2; Thromboxane-A Synthase; Transplantation, Isogeneic | 1996 |
In vivo effect of OPC15161, a superoxide scavenger, on anti-Thy1 nephritis.
Topics: Albuminuria; Animals; Free Radical Scavengers; Glomerulonephritis; Immunohistochemistry; Kidney; Kidney Function Tests; Male; Pyrazines; Rats; Rats, Wistar; Superoxides; Thy-1 Antigens | 1996 |